Investegate |NOVARTIS AG CHF0.50(REGD) Announcements | NOVARTIS AG CHF0.50(REGD): Novartis Cosentyx® gains positive CHMP opinion for hidradenitis suppurativa
Investegate announcements from NOVARTIS AG CHF0.50(REGD), Novartis Cosentyx® gains positive CHMP opinion for hidradenitis suppurativa